During the past decade, Urban Health Plan, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urban Health Plan, Inc." are "Asthma" (2 trials). Many other conditions were trialed in "Urban Health Plan, Inc." in a lesser frequency.

Most popular intervention types in "Urban Health Plan, Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (1 trials), "Omalizumab" (1 trials), "Placebo" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urban Health Plan, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Urban Health Plan, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Urban Health Plan, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urban Health Plan, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".